1.Baliyan V,
Das CJ,
Sharma R,
Gupta AK.
Diffusion weighted imaging: Technique and applications. World J Radiol.
2016;8(9):785-798.
2.Beaulieu C.
The basis of anisotropic water diffusion int he nervous system- a technical review. NMR Biomed 2002:15:325-455.
3.Moritani,
T.
Ekholm,
S.
Westesson,
PA.
Diffusion-Weighted MR Imaging of the Brain.
Springer.
(2009) ISBN:3540787852.
4.UK.
PP.
Diffusion MRI : Theory,
Methods,
and Applications,
Theory,
Methods,
and Applications.
Oxford University Press,
USA.
(2010) ISBN:019970870.
5.Dietrich O,
Biffar A,
Baur-Melnyk A,
et al.
Technical aspects of diffusion imaging of the body. Eur J Radiol 2010; 76:314-322.
6.Stejskal EO,
Tanner JE.
Spin diffusion measuremtns: spine echoes in the presence of time-dependant field gradient. J Chem Phys 1965; 42:288-292.
7.Kingsley PB,
Monahan WG.
Selection of the optimum b factor for diffusion-weighted magnetic resonance imaging assessment of ischaemic stroke. Mag Reson Med 2004; 51:996-1001.
8.Hammer M.
MRI Physics: Diffusion weighted imaging.
http://xrayphysics.com/dwi.html.
Published 2013-2014.
Accessed 7th January 2019.
9.Elster AD.
MRI Questions.
http://mriquestions.com.
Published 2018.
Accessed 7th January 2019.
10.Qayyum A.
Diffusion-weighted iamging in the abodmen and pelvis: concepts and applications. Radiographics 2009; 29:1797-1810.
11.Schaefer PW,
Grant PE,
Gonzalez RG.
Diffusion-weighted MR imaging of the brain.
Radiology 2000; 217:331-345.
12.Kim SH,
Lee JM Hong SH et al.
Locally advanced rectal caner: added value of diffusion weighted MR imaging in the evalution of tumor response to neo-adjuvant chemo-and radiation therapy.
Radiology 2009;253(1):116-125.
13.Qi F,
Jun S,
Qi QY et al.
Utility of the diffusion-weighted imaging for activity evaluation in Crohn’s disease patients underwent magnetic resonance enterography. BMC Gastroenterol. 2015;15:12.
14.Pendsé DA,
Makanyanga JC,
Plumb AA,
et al.
Diffusion-weighted imaging for evaluating inflammatory activity in Crohn's disease: comparison with histopathology,
conventional MRI activity scores,
and faecal calprotectin. Abdom Radiol (NY).
2016;42(1):115-123.
15.Bruegel M, Holzapfel K, Gaa J et al.
Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008;18(3):477–485.
16.Qayyum A, Nystrom M, Noworolski SM,
et al.
Accuracy of MR biometrics as a tool for predicting liver fibrosis in non-alcoholic fatty liver disease: incremental benefit of steatosis-corrected apparent diffusion coefficient [abstr].
In: RSNA Scientific Assembly and Annual Meeting Program.
Oak Brook,
Ill: Radiological Society of North America, 2008; 617.
17.Rechichi,
G.,
Galimberti,
S.,
Signorelli,
M.
et al. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade,
depth of myometrial invasion,
and presence of lymph node metastases.AJR Am J Roentgenol. 2011; 197: 256–262
18.Koh DM, Scurr E, Collins D et al.. Predicting response of colorectal hepatic metastasis: value of pre-treatment apparent diffusion coefficients. AJR Am J Roentgenol 2007;188(4):1001–1008.
19.Heijnen LA,
Lambregts DM,
Mondal D.
Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes.
Eur Radiol. 2013 Dec;23(12):3354-60.
20.van Heeswijk MM,
Doenja M,
Labregts J et al.
DWI for assessment of Rectal Cancer Nodes after Chemoradiotherapy: Is the absence of nodes at DWI proof of a negative nodal status? AJR Am J Roentgenol 2017 208:3, W79-W84.
21.Pawlyn C,
Fowkes L,
Otero S,
et al.
Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?. Leukemia.
2016;30(6):1446-8.